HMB-001 bispecific antibody shows promise for treating Glanzmann thrombasthenia Feb. 15, 2022 No Comments
A microbiota-macrophage-iron axis regulates hematopoietic stem cell fate decisions under stress Feb. 3, 2022 No Comments
Emendo Biotherapeutics develops CRISPR-based ex-vivo gene editing strategy for ELANE neutropenia Dec. 29, 2021 No Comments
Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders Dec. 17, 2021 No Comments
RSS